Recent advances in various areas of clinical medicine, diagnostics and genetic testing have created a significant opportunity for the development of high value genetic tests to enable the practice of personalized medicine.
The availability of affordable Next-Generation Sequencing systems provides the foundation on which PCR based technologies can be applied to address a wide range of unmet needs.
Multiplex PCR is a molecular biology technique for the amplification of multiple genomic targets in a single PCR experiment.
Multiplex Amplification of Specific Targets for Resequencing (MASTR)
MASTR assays offer an innovative combination of premixed PCR primers in a ready-to-use format, enabling enhanced target amplification for DNA-based diagnostics.
MASTR assays serve as front-end amplification for sequence analysis for all Next-Generation Sequencing (NGS) systems. The technology is based on “target amplification” rather than classic target enrichment.